{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:36:09Z","timestamp":1758962169932},"reference-count":92,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although many neuromuscular conditions are evaluated on an outpatient basis owing to their chronic or progressive nature, more urgent evaluation and management is often required for the inpatient presenting with acute to subacute focal or generalized numbness or weakness. This review focuses on clinical pattern recognition and basic anatomic localization principles to aid in the identification of common, as well as some less frequently encountered, neuromuscular disorders in hospitalized patients. The characteristic clinical and diagnostic features, associated complications, and recommended treatments of key neuromuscular conditions with acute and subacute manifestations are discussed. These conditions can be life-threatening in some cases, such as in Guillain\u2013Barr\u00e9 syndrome, owing to associated oropharyngeal weakness, respiratory failure, or marked dysautonomia. Prompt recognition of the clinical and pathologic features is therefore necessary to reduce associated morbidity and mortality.<\/jats:p>","DOI":"10.1055\/s-0041-1733794","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T22:34:42Z","timestamp":1633646082000},"page":"493-510","source":"Crossref","is-referenced-by-count":2,"title":["Inpatient Diagnosis and Management of Neuromuscular Disorders"],"prefix":"10.1055","volume":"41","author":[{"given":"Leana","family":"Doherty","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Neuromuscular Medicine, University of North Carolina School of Medicine Chapel Hill, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"ref1","first-page":"2651","volume-title":"Peripheral neuropathy","author":"V Chaudhry","year":"2008","edition":"17th ed."},{"key":"ref2","first-page":"487","article-title":"Common entrapment neuropathies","volume":"23","author":"L D Hobson-Webb","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4471-3834-1_5","volume-title":"Classification of neuromuscular diseases","author":"M Swash","year":"1997"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/jnnp.2008.151126","article-title":"The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study","volume":"79","author":"D LH Bennett","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1529-8027.2010.00281.x","article-title":"Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary","volume":"15","author":"M P Collins","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"ref6","volume-title":"Neuromuscular Disorders","author":"A Amato","year":"2015","edition":"2nd ed."},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ncl.2019.01.013","article-title":"Peripheral nerve vasculitis: classification and disease associations","volume":"37","author":"K G Gwathmey","year":"2019","journal-title":"Neurol Clin"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/mus.20131","article-title":"Brachial plexopathies: classification, causes, and consequences","volume":"30","author":"M A Ferrante","year":"2004","journal-title":"Muscle Nerve"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/brain\/awh722","article-title":"The clinical spectrum of neuralgic amyotrophy in 246 cases","volume":"129","author":"N van Alfen","year":"2006","journal-title":"Brain"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mus.25008","article-title":"Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment","volume":"53","author":"J JJ Van Eijk","year":"2016","journal-title":"Muscle Nerve"},{"issue":"09","key":"ref11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.0000000000004297","article-title":"Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy","volume":"89","author":"J JJ van Eijk","year":"2017","journal-title":"Neurology"},{"issue":"03","key":"ref12","first-page":"CD006976","article-title":"Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis)","volume":"8","author":"N van Alfen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/jnnp.2008.163386","article-title":"Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study","volume":"80","author":"J JJ van Eijk","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pmr.2014.01.001","article-title":"Challenging pain syndromes: Parsonage-Turner syndrome","volume":"25","author":"C C Smith","year":"2014","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/practneurol-2018-002105","article-title":"Diabetic amyotrophy: a painful radiculoplexus neuropathy","volume":"19","author":"D Llewelyn","year":"2019","journal-title":"Pract Neurol"},{"key":"ref16","first-page":"1241","article-title":"General approach to peripheral nerve disorders","volume":"23","author":"J A Russell","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"issue":"01","key":"ref17","first-page":"139","article-title":"Medication, toxic, and vitamin-related neuropathies","volume":"18","author":"B Morrison","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.24943","article-title":"Sensory neuronopathies","volume":"53","author":"K G Gwathmey","year":"2016","journal-title":"Muscle Nerve"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11910-017-0784-4","article-title":"Sensory neuronopathies","volume":"17","author":"A Crowell","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jns.12298","article-title":"Small-fiber neuropathy: expanding the clinical pain universe","volume":"24","author":"M Sopacua","year":"2019","journal-title":"J Peripher Nerv Syst"},{"issue":"45","key":"ref21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.15585\/mmwr.mm6845a5","article-title":"Progress toward poliomyelitis eradication - Pakistan, January 2018-September 2019","volume":"68","author":"C H Hsu","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/oxfordjournals.epirev.a018041","article-title":"Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance","volume":"22","author":"A Marx","year":"2000","journal-title":"Epidemiol Rev"},{"key":"ref23","first-page":"383","volume-title":"Poliomyelitis and post-poliomyelitis syndrome","author":"K Boonyapisit","year":"2014"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0040-1705123","article-title":"Acute flaccid myelitis: a clinical review","volume":"40","author":"O C Murphy","year":"2020","journal-title":"Semin Neurol"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/rmv.501","article-title":"Manifestations of West Nile neuroinvasive disease","volume":"16","author":"J J Sejvar","year":"2006","journal-title":"Rev Med Virol"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/practneurol-2017-001878","article-title":"Porphyria: often discussed but too often missed","volume":"18","author":"R O'Malley","year":"2018","journal-title":"Pract Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2019.05.021","article-title":"Porphyria: a rare differential diagnosis of polyradiculoneuropathy","volume":"402","author":"F Ali","year":"2019","journal-title":"J Neurol Sci"},{"issue":"06","key":"ref28","first-page":"1536","article-title":"Approach to muscle and neuromuscular junction disorders","volume":"25","author":"M Pasnoor","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"A Vincent","year":"2001","journal-title":"Lancet"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"D Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"M K Hehir","year":"2018","journal-title":"Neurol Clin"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"K Lazaridis","year":"2020","journal-title":"Front Immunol"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0022-510X(83)90095-3","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients","volume":"58","author":"P C Limburg","year":"1983","journal-title":"J Neurol Sci"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.41.4.520","article-title":"Diagnosis of thymoma in myasthenics using anti-striated muscle antibodies: predictive value and gain in diagnostic certainty","volume":"41","author":"D J Lanska","year":"1991","journal-title":"Neurology"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2008-1041257","article-title":"Thymoma: diagnosis and management","volume":"10","author":"M H Rivner","year":"1990","journal-title":"Semin Neurol"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.clinph.2011.02.026","article-title":"Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation","volume":"122","author":"R Witoonpanich","year":"2011","journal-title":"Clin Neurophysiol"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: site of \u201cinnate autoimmunity\u201d?","volume":"44","author":"P Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"issue":"25","key":"ref38","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"D B Drachman","year":"1994","journal-title":"N Engl J Med"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.semarthrit.2013.12.005","article-title":"The co-existence of myasthenia gravis in patients with myositis: a case series","volume":"43","author":"J J Paik","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0038-1676838","article-title":"Acute manifestations of neuromuscular disease","volume":"39","author":"C Edmundson","year":"2019","journal-title":"Semin Neurol"},{"issue":"23","key":"ref41","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"D Barth","year":"2011","journal-title":"Neurology"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"J T Guptill","year":"2011","journal-title":"Muscle Nerve"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"D B Sanders","year":"2016","journal-title":"Neurology"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40265-018-0875-9","article-title":"Eculizumab: a review in generalized myasthenia gravis","volume":"78","author":"S Dhillon","year":"2018","journal-title":"Drugs"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"G I Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26070","article-title":"Neuromuscular complications of immune checkpoint inhibitor therapy","author":"N A Kolb","year":"2018","journal-title":"Muscle Nerve"},{"issue":"S 04","key":"ref47","doi-asserted-by":"crossref","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"J BAG Haanen","year":"2017","journal-title":"Ann Oncol"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies","volume":"10","author":"M J Titulaer","year":"2011","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"M J Titulaer","year":"2011","journal-title":"Eur J Neurol"},{"issue":"08","key":"ref50","first-page":"e5450","article-title":"Recent advances and therapeutic options in Lambert-Eaton myasthenic syndrome","volume":"11","author":"A Anwar","year":"2019","journal-title":"Cureus"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.47.3.678","article-title":"Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"47","author":"P G Bain","year":"1996","journal-title":"Neurology"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiologic review","volume":"129","author":"R L Shapiro","year":"1998","journal-title":"Ann Intern Med"},{"issue":"06","key":"ref53","first-page":"1785","article-title":"Lambert-Eaton myasthenic syndrome, botulism, and immune checkpoint inhibitor-related myasthenia gravis","volume":"25","author":"A C Guidon","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"S 01","key":"ref54","first-page":"S1","article-title":"Making the best of the evidence: toward national clinical guidelines for botulism","volume":"66","author":"J Sobel","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mus.10053","article-title":"Rhabdomyolysis: a review","volume":"25","author":"J D Warren","year":"2002","journal-title":"Muscle Nerve"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/B978-0-444-63599-0.00029-6","article-title":"Intensive care unit-acquired weakness","volume":"141","author":"J Horn","year":"2017","journal-title":"Handb Clin Neurol"},{"issue":"01","key":"ref57","first-page":"CD006832","article-title":"Interventions for preventing critical illness polyneuropathy and critical illness myopathy","author":"G Hermans","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1097\/CCM.0b013e3181b6ef67","article-title":"A framework for diagnosing and classifying intensive care unit-acquired weakness","volume":"37","author":"R D Stevens","year":"2009","journal-title":"Crit Care Med"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<665::AID-MUS2>3.0.CO;2-6","article-title":"Direct muscle stimulation in acute quadriplegic myopathy","volume":"20","author":"M M Rich","year":"1997","journal-title":"Muscle Nerve"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","article-title":"Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis","volume":"10","author":"N Latronico","year":"2011","journal-title":"Lancet Neurol"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1164\/rccm.200605-665OC","article-title":"Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit","volume":"175","author":"G Hermans","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref62","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"A Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"I E Lundberg","year":"2016","journal-title":"J Intern Med"},{"issue":"02","key":"ref64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2008-1062267","article-title":"Inflammatory myopathies: evaluation and management","volume":"28","author":"S A Greenberg","year":"2008","journal-title":"Semin Neurol"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(02)00030-3","article-title":"Muscle biopsy findings in inflammatory myopathies","volume":"28","author":"M C Dalakas","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"ref66","first-page":"74","article-title":"The role of imaging in evaluating patients with idiopathic inflammatory myopathies","volume":"36","author":"K Kub\u00ednov\u00e1","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1179547619855370","DOI":"10.1177\/1179547619855370","article-title":"Dermatomyositis: an acute flare and current treatments","volume":"12","author":"J Okogbaa","year":"2019","journal-title":"Clin Med Insights Case Rep"},{"issue":"08","key":"ref68","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"E Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"issue":"23","key":"ref69","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"R De Lorenzo","year":"2018","journal-title":"Neurology"},{"issue":"01","key":"ref70","first-page":"87","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, the Netherlands, 14-16 October 2016","volume":"28","author":"Y Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"I Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with up-regulation of MHC-I associated with statin therapy","volume":"17","author":"M Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis","volume":"7","author":"A L Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"I Pinal-Fernandez","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"05","key":"ref75","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0039-1694747","article-title":"A clinician's approach to peripheral neuropathy","volume":"39","author":"P Siao","year":"2019","journal-title":"Semin Neurol"},{"issue":"06","key":"ref76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barr\u00e9 syndrome: an update","volume":"16","author":"S Vucic","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"05","key":"ref77","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"R DM Hadden","year":"1998","journal-title":"Ann Neurol"},{"issue":"17","key":"ref78","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","article-title":"The Guillain-Barr\u00e9 syndrome","volume":"326","author":"A H Ropper","year":"1992","journal-title":"N Engl J Med"},{"issue":"S 02","key":"ref79","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome","volume":"176","author":"R AC Hughes","year":"1997","journal-title":"J Infect Dis"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"A K Asbury","year":"1990","journal-title":"Ann Neurol"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1941875210396379","article-title":"Inpatient management of Guillain-Barr\u00e9 syndrome","volume":"1","author":"M Harms","year":"2011","journal-title":"Neurohospitalist"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)","volume":"255","author":"M Fisher","year":"1956","journal-title":"N Engl J Med"},{"issue":"05","key":"ref83","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00415-008-0775-0","article-title":"Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases","volume":"255","author":"M Ito","year":"2008","journal-title":"J Neurol"},{"issue":"08","key":"ref84","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. The Guillain-Barr\u00e9 syndrome Study Group","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"ref85","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"S Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"09","key":"ref86","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","author":"R AC Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barr\u00e9 syndrome: a randomized trial","volume":"116","author":"R Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2019-321496","article-title":"Original research: second IVIg course in Guillain-Barr\u00e9 syndrome with poor prognosis: the non-randomised ISID study","volume":"91","author":"C Verboon","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000007719","article-title":"Current treatment practice of Guillain-Barr\u00e9 syndrome","volume":"93","author":"C Verboon","year":"2019","journal-title":"Neurology"},{"issue":"03","key":"ref90","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome","volume":"41","author":"J C Rapha\u00ebl","year":"1997","journal-title":"Ann Neurol"},{"issue":"14","key":"ref91","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.wnl.0000258673.31824.61","article-title":"Intravenous immunoglobulin therapy for Miller Fisher syndrome","volume":"68","author":"M Mori","year":"2007","journal-title":"Neurology"},{"key":"ref92","first-page":"1295","article-title":"Guillain-Barr\u00e9 syndrome","volume":"23","author":"P D Donofrio","year":"2017","journal-title":"Continuum (Minneap Minn)"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1733794.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T22:39:59Z","timestamp":1633646399000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1733794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":92,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2021,10,7]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1733794","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}